ES2007775A6 - Procedimiento para la obtencion de fibronectina del plasma y de fracciones plasmaticas. - Google Patents

Procedimiento para la obtencion de fibronectina del plasma y de fracciones plasmaticas.

Info

Publication number
ES2007775A6
ES2007775A6 ES8703787A ES8703787A ES2007775A6 ES 2007775 A6 ES2007775 A6 ES 2007775A6 ES 8703787 A ES8703787 A ES 8703787A ES 8703787 A ES8703787 A ES 8703787A ES 2007775 A6 ES2007775 A6 ES 2007775A6
Authority
ES
Spain
Prior art keywords
blood plasma
prodn
fibronectin
nectin
fibro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES8703787A
Other languages
English (en)
Inventor
Sanchez Maximo Jesus Jimenez
Gabarro Jose Antonio Poch
Ripoll Jose Vicente Castell
Moliner Maria Jos Gomez-Lechon
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratorios Hubber SA
Original Assignee
Laboratorios Hubber SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratorios Hubber SA filed Critical Laboratorios Hubber SA
Priority to ES8703787A priority Critical patent/ES2007775A6/es
Publication of ES2007775A6 publication Critical patent/ES2007775A6/es
Expired legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)

Abstract

DICHO INVENTO CONSISTE EN UN PROCEDIMIENTO PARA LA OBTENCION DE FIBRONECTINA TANTO DEL PLASMA HUMANO COMO DE ANIMALES CARACTERIZADO POR UN PROCESO DE DISOLUCION QUE CON POSTERIORES CALENTAMIENTOS, ENFRIAMIENTOS Y CENTRIFUGADOS DAN LUGAR A UN PRECIPITADO QUE UNA VEZ CONGELADO Y DISUELTO DA LUGAR A UN PRECIPITADO QUE UNA VEZ CONGELADO Y DISUELTO DA LUGAR A UNA CONCENTRACION DE FIBRONECTINA QUE TENDRA APLICACION PARA USO TERAPEUTICO HUMANO Y PARA CULTIVOS CELULARES IN VITRO.
ES8703787A 1987-12-31 1987-12-31 Procedimiento para la obtencion de fibronectina del plasma y de fracciones plasmaticas. Expired ES2007775A6 (es)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ES8703787A ES2007775A6 (es) 1987-12-31 1987-12-31 Procedimiento para la obtencion de fibronectina del plasma y de fracciones plasmaticas.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES8703787A ES2007775A6 (es) 1987-12-31 1987-12-31 Procedimiento para la obtencion de fibronectina del plasma y de fracciones plasmaticas.

Publications (1)

Publication Number Publication Date
ES2007775A6 true ES2007775A6 (es) 1989-07-01

Family

ID=8253973

Family Applications (1)

Application Number Title Priority Date Filing Date
ES8703787A Expired ES2007775A6 (es) 1987-12-31 1987-12-31 Procedimiento para la obtencion de fibronectina del plasma y de fracciones plasmaticas.

Country Status (1)

Country Link
ES (1) ES2007775A6 (es)

Similar Documents

Publication Publication Date Title
DE69721006D1 (de) Verwendung des modifizierten eigenen blutes zur behandlung von autoimmunerkrankungen
NO913700L (no) Ekspresjon av eksogene polynukleotidsekvenser i et virveldyr.
BG60253B1 (bg) Човешки тъканен плазминогенен активатор
IL88208A0 (en) Acylated uridine and cytidine and uses thereof
HUT43414A (en) Method and device for introducing physiological solution into human or animal organism as well as method of temperature control and heating device suitable to this method and device
ATE67666T1 (de) Verwendung von sulfomucopolysacchariden zur therapeutischen behandlung von krankheiten des alzheimertyps.
ES2002129A6 (es) Molde flexible para congelar pequenos cuerpos de hielo, y cierre para la obturacion hermetica a los fluidos, de moldes y similares.
ATE81254T1 (de) Neovaskularisierungsinhibitoren und deren herstellung.
ES8103162A1 (es) Un procedimiento para la preparacion de interferon tipo ii.
AU2155795A (en) Alphavirus cdna vectors
ES2060942T3 (es) Terapia genetica utilizando celulas estromicas.
NO179953C (no) Kvantitativ metode for bestemmelse av 1,4-dihydronikotinamid-adenin-dinukleotid i opplösning, samt engangs enzymelektrode
GB2190382B (en) "enhanced expression of human interleukin-2 or analogues in mammalian cells.
HUT58037A (en) Process for producing n-2,3-butadienyl tri- and tetraaminoalkane derivatives
BR9007115A (pt) Novo trombolitico
DK363088A (da) Dobbeltstrenget rna-korrektion af afvigende metaboliske baner, der staar i forbindelse med ukontrollerede tumorcelle- og virusvaekstcykler
ES2007775A6 (es) Procedimiento para la obtencion de fibronectina del plasma y de fracciones plasmaticas.
ES8800725A1 (es) Un procedimiento para producir un anticuerpo monoclonal
NZ222089A (en) Endothelial cell harvester with irrigation means for enzyme treatment of blood vessel
AU6000886A (en) Chromosomal DNA sequence, expression vector for human tissue plasminogen activating factor, cultured cells transfected with same and method of producing said activating factor
DK0538330T3 (da) Beta-Alethin-anvendelse til celledyrkning og terapi
DE68924222D1 (de) Megakaryocytopoietin, seine Herstellung und Benutzung.
NO912685D0 (no) Nye radikale litiumftalocyaninkrystaller, deres fremstillingsprosess og deres bruk i in vivo bestemmelse av molekylaert oksygen.
SE7903262L (sv) Forfarande for framstellning av biokompatibla material
SE9300509D0 (sv) Peg treatment

Legal Events

Date Code Title Description
SA6 Expiration date (snapshot 920101)

Free format text: 2007-12-31